NT5E and cancer: The results showed that high CD73 expression was significantly correlated with poorer OS in various cancers [HR 1.48 (95% CI: 1.04–2.10); P = 0.030] but large heterogeneity existed (I2 = 78.0%; P < 0.05; Fig. 3a).